Stay informed on the latest Truth Social posts from Donald Trump (@realDonaldTrump) without the doomscrolling. Consider it a public service for your mental health. (Why?)
Filtering by entity: Donald Trump | Clear Filter
Summary:The post presents a letter from The White House, signed by Donald Trump, addressed to EMD Serono, demanding that pharmaceutical manufacturers implement "Most-Favored-Nation" drug pricing for American patients by September 29, 2025, to significantly lower prescription drug costs and end perceived "global freeloading."
Sentiment:Directive
Key Claims:
- An Executive Order titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients" was signed on May 12, 2025, to ensure Americans pay the same drug prices as other developed nations.
- Brand name drug prices in the United States are up to three times higher than elsewhere.
- Pharmaceutical companies are called upon to extend Most-Favored-Nation (MFN) pricing to Medicaid for existing drugs.
- Pharmaceutical companies are called upon to guarantee MFN pricing for newly-launched drugs to Medicare, Medicaid, and commercial payers.
- Increased revenues earned abroad by manufacturers must be repatriated to lower drug prices for American patients and taxpayers.
- Manufacturers must provide for direct purchasing at MFN pricing through Direct-to-Consumer (DTC) and/or Direct-to-Business (DTB) models.
- The Administration will deploy every tool in its arsenal to protect American families if manufacturers refuse to comply with demands.
- Binding commitments to these goals are expected by September 29, 2025.
Potential Market Impact (S&P 500):7/10
Potential Geopolitical Risk:1/10
Potential Global Cross-Asset Impact:7/10
Summary:The White House, under Donald Trump, has issued a directive to AstraZeneca and all drug manufacturers to implement Most-Favored-Nation (MFN) drug pricing for American patients, aiming to stop other nations from "freeloading" on American innovation and to lower prescription drug costs significantly by September 29, 2025.
Sentiment:Directive/Demanding
Key Claims:
- Americans currently pay up to three times more for identical prescription drugs than patients in other developed nations.
- Other nations are "freeloading" on American innovation in drug development.
- An Executive Order on "Most-Favored-Nation Prescription Drug Pricing" was signed on May 12, 2025.
- Drug manufacturers are called upon to extend MFN pricing to Medicaid, guarantee MFN pricing for newly-launched drugs, return increased revenues from abroad to American patients, and offer direct purchasing at MFN prices.
- The Administration is prepared to use every tool to protect Americans from abusive drug pricing practices if cooperation is not met.
- Binding commitments for these goals are expected by September 29, 2025.
Potential Market Impact (S&P 500):8/10
Potential Geopolitical Risk:0/10
Potential Global Cross-Asset Impact:7/10
Summary:A letter from the White House dated July 31, 2025, sent to Amgen, demands that drug manufacturers implement actions within 60 days, by September 29, 2025, to lower prescription drug prices for American patients to Most-Favored-Nation rates. The letter asserts that the US currently pays significantly more for brand name drugs than other developed nations due to 'global freeloading' and highlights an Executive Order signed on May 12, 2025, aimed at addressing this disparity.
Sentiment:Directive
Key Claims:
- An Executive Order titled 'Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients' was signed on May 12, 2025.
- Brand name drug prices in the United States are up to three times higher than elsewhere, attributed to 'global freeloading' and an 'unacceptable burden' on American families.
- Amgen and all manufacturers are called upon to implement specific actions within 60 days to address inflated drug prices.
- Required actions include extending Most-Favored-Nation (MFN) pricing to Medicaid, guaranteeing MFN pricing for newly-launched drugs, returning increased revenues from abroad to American patients and taxpayers, and providing for direct purchasing at MFN pricing.
- The administration is prepared to deploy 'every tool in our arsenal' to protect American families from 'abusive drug pricing practices' if manufacturers do not comply.
- The deadline for achieving these goals is September 29, 2025.
Potential Market Impact (S&P 500):8/10
Potential Geopolitical Risk:2/10
Potential Global Cross-Asset Impact:7/10
Summary:A telephone conversation with Mexican President Claudia Sheinbaum was completed, resulting in an agreement to extend existing tariffs on Fentanyl, cars, steel, aluminum, and copper for 90 days. Mexico also agreed to immediately terminate its non-tariff trade barriers. Both parties will negotiate a new trade deal within or potentially beyond the 90-day period, and cooperation on border security, including drugs and illegal immigration, will continue.
Sentiment:Negotiating
Key Claims:
- A very successful telephone conversation was held with Mexican President Claudia Sheinbaum.
- The U.S. and Mexico are increasing their mutual understanding.
- The complexities of a deal with Mexico are unique due to border issues.
- The exact same deal as the last short period was extended for 90 days.
- Mexico will continue to pay a 25% Fentanyl Tariff, 25% Tariff on Cars, and 50% Tariff on Steel, Aluminum, and Copper.
- Mexico has agreed to immediately terminate its Non Tariff Trade Barriers.
- Talks will occur over the next 90 days to sign a trade deal within or beyond that period.
- Key U.S. officials were present at the meeting: JD Vance, Scott Bessent, Marco Rubio, Howard Lutnick, Jamieson Greer, Susie Wiles, and Stephen Miller.
- Continued cooperation on border security, including drugs, drug distribution, and illegal immigration into the United States, will take place.
Potential Market Impact (S&P 500):5/10
Potential Geopolitical Risk:0/10
Potential Global Cross-Asset Impact:5/10
Summary:The post asserts Donald Trump's identity as "President Trump, Dealmaker In-Chief," featuring an image of him in a dynamic pose with his arm raised.
Sentiment:Triumphant
Key Claims:
- Donald Trump is President
- Donald Trump is the 'Dealmaker In-Chief'
Potential Market Impact (S&P 500):0/10
Potential Geopolitical Risk:0/10
Potential Global Cross-Asset Impact:0/10
Summary:The post displays Donald Trump alongside a Business Insider headline stating that US economic growth for the last quarter was stronger than anticipated.
Sentiment:Triumphant
Key Claims:
- US economic growth for the last quarter was hotter than expected.
Potential Market Impact (S&P 500):4/10
Potential Geopolitical Risk:0/10
Potential Global Cross-Asset Impact:2/10
Summary:Donald Trump secured a historic trade deal with the European Union, which involves Europe committing to purchase $750 billion in U.S. energy.
Sentiment:Triumphant
Key Claims:
- Trump reached a historic trade deal with the EU.
- Europe is set to buy $750 billion in U.S. energy as part of the deal.
Potential Market Impact (S&P 500):8/10
Potential Geopolitical Risk:0/10
Potential Global Cross-Asset Impact:7/10
Summary:The post depicts Donald Trump alongside a Fox Business graphic announcing that July tariff revenues have established a new monthly record, with $150 billion collected so far in 2025.
Sentiment:Triumphant
Key Claims:
- July tariff revenues broke a monthly record
- 150 billion dollars in tariff revenue has been collected in 2025
Potential Market Impact (S&P 500):6/10
Potential Geopolitical Risk:0/10
Potential Global Cross-Asset Impact:7/10
Summary:The post asserts that Q2 GDP data validates economic policies, specifically tariffs, and refutes earlier skeptical predictions from various media outlets regarding economic performance and potential damage.
Sentiment:Vindicative
Key Claims:
- Q2 GDP data proves that media predictions regarding economic outcomes were incorrect.
- Media outlets had previously expressed skepticism about Trump's tariffs and their economic impact.
- Reports suggested Trump's economic revival efforts were falling short in his first 100 days.
- Media outlets claimed that Trump's actions would result in economic damage.
- The Q2 GDP data demonstrates the success of Trump's economic policies, contrary to media narratives.
Potential Market Impact (S&P 500):3/10
Potential Geopolitical Risk:0/10
Potential Global Cross-Asset Impact:2/10
Summary:Donald Trump expresses gratitude for remarks from Ralph Norman, who regards him as a phenomenon for making the federal government accountable.
Sentiment:Triumphant
Key Claims:
- Donald Trump is a phenomenon for his work.
- Donald Trump is making the federal government accountable.
- Donald Trump expresses gratitude for supportive remarks.
Potential Market Impact (S&P 500):1/10
Potential Geopolitical Risk:0/10
Potential Global Cross-Asset Impact:0/10